IBDEI21V ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34778,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,34778,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,34778,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,34779,0)
 ;;=R73.09^^131^1692^15
 ;;^UTILITY(U,$J,358.3,34779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34779,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,34779,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,34779,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,34780,0)
 ;;=R73.9^^131^1692^84
 ;;^UTILITY(U,$J,358.3,34780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34780,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,34780,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,34780,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,34781,0)
 ;;=R76.11^^131^1692^142
 ;;^UTILITY(U,$J,358.3,34781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34781,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,34781,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,34781,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,34782,0)
 ;;=R79.1^^131^1692^3
 ;;^UTILITY(U,$J,358.3,34782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34782,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,34782,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,34782,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,34783,0)
 ;;=R82.5^^131^1692^69
 ;;^UTILITY(U,$J,358.3,34783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34783,1,3,0)
 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,34783,1,4,0)
 ;;=4^R82.5
 ;;^UTILITY(U,$J,358.3,34783,2)
 ;;=^5019605
 ;;^UTILITY(U,$J,358.3,34784,0)
 ;;=R82.6^^131^1692^26
 ;;^UTILITY(U,$J,358.3,34784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34784,1,3,0)
 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
 ;;^UTILITY(U,$J,358.3,34784,1,4,0)
 ;;=4^R82.6
 ;;^UTILITY(U,$J,358.3,34784,2)
 ;;=^5019606
 ;;^UTILITY(U,$J,358.3,34785,0)
 ;;=R82.7^^131^1692^27
 ;;^UTILITY(U,$J,358.3,34785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34785,1,3,0)
 ;;=3^Abnormal Urine Microbiological Findings
 ;;^UTILITY(U,$J,358.3,34785,1,4,0)
 ;;=4^R82.7
 ;;^UTILITY(U,$J,358.3,34785,2)
 ;;=^5019607
 ;;^UTILITY(U,$J,358.3,34786,0)
 ;;=R82.8^^131^1692^23
 ;;^UTILITY(U,$J,358.3,34786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34786,1,3,0)
 ;;=3^Abnormal Urine Cytology/Histology Findings
 ;;^UTILITY(U,$J,358.3,34786,1,4,0)
 ;;=4^R82.8
 ;;^UTILITY(U,$J,358.3,34786,2)
 ;;=^5019608
 ;;^UTILITY(U,$J,358.3,34787,0)
 ;;=R82.90^^131^1692^25
 ;;^UTILITY(U,$J,358.3,34787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34787,1,3,0)
 ;;=3^Abnormal Urine Findings,Unspec
 ;;^UTILITY(U,$J,358.3,34787,1,4,0)
 ;;=4^R82.90
 ;;^UTILITY(U,$J,358.3,34787,2)
 ;;=^5019609
 ;;^UTILITY(U,$J,358.3,34788,0)
 ;;=R82.91^^131^1692^49
 ;;^UTILITY(U,$J,358.3,34788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34788,1,3,0)
 ;;=3^Chromoabnormalities of Urine NEC
 ;;^UTILITY(U,$J,358.3,34788,1,4,0)
 ;;=4^R82.91
 ;;^UTILITY(U,$J,358.3,34788,2)
 ;;=^5019610
 ;;^UTILITY(U,$J,358.3,34789,0)
 ;;=R82.99^^131^1692^24
 ;;^UTILITY(U,$J,358.3,34789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34789,1,3,0)
 ;;=3^Abnormal Urine Findings NEC
 ;;^UTILITY(U,$J,358.3,34789,1,4,0)
 ;;=4^R82.99
 ;;^UTILITY(U,$J,358.3,34789,2)
 ;;=^5019611
 ;;^UTILITY(U,$J,358.3,34790,0)
 ;;=R89.9^^131^1692^19
 ;;^UTILITY(U,$J,358.3,34790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34790,1,3,0)
 ;;=3^Abnormal Organ/Tissue Specimen Findings,Unspec
 ;;^UTILITY(U,$J,358.3,34790,1,4,0)
 ;;=4^R89.9
 ;;^UTILITY(U,$J,358.3,34790,2)
 ;;=^5019702
 ;;^UTILITY(U,$J,358.3,34791,0)
 ;;=R90.0^^131^1692^98
